Medicine and Dentistry
Outpatient
100%
Antimicrobial Therapy
92%
Infection
91%
Meropenem
82%
Escherichia coli
59%
Piperacillin/Tazobactam
54%
Beta-Lactamase
54%
Bloodstream Infection
44%
Carbapenemase
40%
Antibiotic Therapy
38%
Ceftriaxone
38%
Bacterial Infection
38%
Inosine Phosphate
36%
Infectious Disease
36%
Febrile Infant
36%
Clinician
32%
Urinary Tract Infection
31%
Antibiotic Resistance
26%
Blood Culture
26%
Systemic Mycosis
22%
Mucormycosis
22%
Klebsiella
22%
Systematic Review
21%
Randomized Controlled Trial
21%
Risk Stratification
21%
Pathogen
20%
Catheter Thrombosis
18%
Infective Endocarditis
18%
Procalcitonin
18%
Tigecycline
18%
Motor Vehicle Accident
18%
Bacterial Pneumonia
18%
Telemedicine
18%
Klebsiella pneumoniae
18%
Ertapenem
18%
Meta-Analysis
18%
Prospective Cohort Study
18%
2009 H1N1 Influenza
18%
Patient-Data
18%
Efficacy Study
18%
Omadacycline
18%
Helicobacter Infection
18%
Mycosis
18%
Mycobacterium abscessus
18%
Ambulatory Care
18%
Continuous Infusion
18%
Encephalitis
18%
Carbapenem
17%
Adverse Event
15%
Clinical Feature
15%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
58%
Antimicrobial Therapy
47%
Bloodstream Infection
42%
Escherichia coli
38%
Mucormycosis
38%
Ceftriaxone
36%
Piperacillin Plus Tazobactam
36%
Meropenem
36%
Antimicrobial Resistance
24%
Urinary Tract Infection
24%
Randomized Controlled Trial
21%
Bacterial Infection
20%
Klebsiella
20%
Helicobacter Infection
18%
Bacterial Pneumonia
18%
Klebsiella pneumoniae
18%
Tigecycline
18%
Bacterial Endocarditis
18%
Procalcitonin
18%
Prospective Cohort Study
18%
Omadacycline
18%
Mycobacterium abscessus
18%
2009 H1N1 Influenza
18%
Efficacy Study
18%
Posaconazole
18%
Ertapenem
18%
Antibiotic Therapy
18%
Helicobacter Pylori
14%
Adverse Event
13%
Route of Administration
12%
Carbapenem
11%
Amphotericin B
11%
Levofloxacin
10%
Carbapenem Derivative
9%
Third Generation Cephalosporin
9%
Nausea
9%
Clarithromycin
7%
Extended Spectrum Beta Lactamase
7%
Adverse Outcome
7%
Skin Disease
7%
Infectious Agent
6%
Comorbidity
6%
Clinical Feature
6%
Subcutaneous Injection
6%
Infection Complication
6%
Antibiotics
5%
Carbapenem Resistance
5%
Cohort Study
5%
Nursing and Health Professions
Infection
82%
Antimicrobial Stewardship
73%
Practice Guideline
52%
Clinical Audit
38%
Diseases
38%
Antiinfective Agent
33%
Hospital Readmission
22%
Blood Culture
21%
Systematic Review
21%
Tertiary Care Center
18%
Rehabilitation Center
18%
Bacterial Endocarditis
18%
Procalcitonin
18%
Febrile Infant
18%
Prospective Cohort Study
18%
Patient Coding
18%
Meta Analysis
18%
Methicillin-Resistant Staphylococcus Aureus
18%
2009 H1N1 Influenza
18%
Omadacycline
18%
Antimicrobial Therapy
16%
Bacterial Infection
15%
Confidence Interval
12%
Diabetes Mellitus
12%
Treatment Outcome
12%
Patient Referral
11%
Foot Ulcer
9%
Liver Disease
9%
Piperacillin Plus Tazobactam
9%
Adverse Outcome
8%
Urinary Tract Infection
7%
Medical Staff
7%
Syndrome
6%
Turnaround Time
6%
Sepsis
6%
Influenza A (H1N1)
6%
Gram Staining
6%
Cohort Analysis
5%
Prevalence
5%